Article
Transient AdeABC-mediated eravacycline resistance in carbapenem-resistant Acinetobacter baumannii ST2: a mutation-independent efflux pump adaptation.
Annals of clinical microbiology and antimicrobials - 12 Jan 2026
Yang Xu, He Nanhao, Haque Anwarul, Mai Ying, Wang Jiong, Xiao Shunian, Zhuo Chao
Abstract excerpt
PURPOSE: This study evaluated the impact of sub-MIC eravacycline exposure on carbapenem-resistant Acinetobacter baumannii with tigecycline MIC ≥ 8 µg/mL in clinical laboratory testing, and analyzed the resistance mechanisms. METHODS: 2144 A. baumannii isolates (2021–2024) from a Chinese tertiary hospital were analyzed for resistance trends. For 43 strains with tigecycline MIC ≥ 8 µg/mL, we conducted: (i) in vitro...
Topics
- Acinetobacter baumannii
- Anti-Bacterial Agents
- Microbial Sensitivity Tests
- Carbapenems
- Humans
- Membrane Transport Proteins
- Tigecycline
- Tetracyclines
- Mutation
- Bacterial Proteins
